Clinical Trials Directory

Trials / Unknown

UnknownNCT01875809

Impact of Catecholamine Spill-over on Outcome After RDN and EP Ablation

Impact of Patient-specific and Procedural Characteristics Like Catecholamine Spill-over on the Long-term Outcome After Renal Denervation and EP Ablation

Status
Unknown
Phase
Study type
Observational
Enrollment
80 (estimated)
Sponsor
University of Witten/Herdecke · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Despite a rapidly increasing number of renal denervation (RDN) procedures, only little is known regarding the patient or procedural characteristics influencing the outcome. None of the detectable variables like number of ablation points, temperature rise, impedance drop, have been shown to correlate with the blood pressure (BP) reduction. In this study, the investigators assess different patient and procedural characteristics, like exact patient medication, stress hormones, heart rate variability, and focus on the change of the catecholamine spill-over, and the impact on BP and heart rate after RDN and after EP ablation. The investigators hypothesize the correlation between reduction of catecholamine spill-over due to denervation and the BP reduction. In this study, the investigators will assess 40 patients undergoing RDN and 40 patients undergoing EP ablation.

Conditions

Timeline

Start date
2013-03-01
Primary completion
2015-02-01
First posted
2013-06-12
Last updated
2013-06-12

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT01875809. Inclusion in this directory is not an endorsement.

Impact of Catecholamine Spill-over on Outcome After RDN and EP Ablation (NCT01875809) · Clinical Trials Directory